60 Degrees Pharmaceuticals (SXTP) EBITDA Margin (QoQ) (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) EBITDA Margin (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - |
| 10 | 60 Degrees Pharmaceuticals | 2.97 Mn | 1.95 Mn | 56,798.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -66,047.00 |
| Dec 31, 2025 | -10,056.00 |
| Sep 30, 2025 | 105,858.00 |
| Jun 30, 2025 | -42,161.00 |
| Mar 31, 2025 | -31,368.00 |
| Dec 31, 2024 | 71,129.00 |
| Sep 30, 2024 | 178,575.00 |
| Jun 30, 2024 | -208,138.00 |
| Mar 31, 2024 | -57,356.00 |
| Dec 31, 2023 | 227,608.00 |
| Sep 30, 2023 | -277,575.00 |
| Jun 30, 2023 | 533,899.00 |
| Sep 30, 2022 | 822.00 |